MX9204845A - COMBINATIONS OF AMMONIUM CHLORIDE COMPOUNDS AND METHOD FOR THE TREATMENT OF VIRAL INFECTIONS. - Google Patents

COMBINATIONS OF AMMONIUM CHLORIDE COMPOUNDS AND METHOD FOR THE TREATMENT OF VIRAL INFECTIONS.

Info

Publication number
MX9204845A
MX9204845A MX9204845A MX9204845A MX9204845A MX 9204845 A MX9204845 A MX 9204845A MX 9204845 A MX9204845 A MX 9204845A MX 9204845 A MX9204845 A MX 9204845A MX 9204845 A MX9204845 A MX 9204845A
Authority
MX
Mexico
Prior art keywords
treatment
ammonium chloride
combinations
viral infections
chloride compounds
Prior art date
Application number
MX9204845A
Other languages
Spanish (es)
Inventor
William C Stacey
Original Assignee
William C Stacey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by William C Stacey filed Critical William C Stacey
Publication of MX9204845A publication Critical patent/MX9204845A/en

Links

Abstract

Esta invención se relaciona con una 'invención' novedosa de cloruro de amonio y cloruro de trimetiamonio y su uso, como un agente terapéutico en el tratamiento a profilaxis de infecciones virales.This invention relates to a novel 'invention' of ammonium chloride and trimethiamonium chloride and its use, as a therapeutic agent in the treatment of viral infection prophylaxis.

MX9204845A 1992-07-14 1992-08-21 COMBINATIONS OF AMMONIUM CHLORIDE COMPOUNDS AND METHOD FOR THE TREATMENT OF VIRAL INFECTIONS. MX9204845A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US91328292A 1992-07-14 1992-07-14

Publications (1)

Publication Number Publication Date
MX9204845A true MX9204845A (en) 1994-01-31

Family

ID=25433123

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9204845A MX9204845A (en) 1992-07-14 1992-08-21 COMBINATIONS OF AMMONIUM CHLORIDE COMPOUNDS AND METHOD FOR THE TREATMENT OF VIRAL INFECTIONS.

Country Status (1)

Country Link
MX (1) MX9204845A (en)

Similar Documents

Publication Publication Date Title
ES2058892T3 (en) USE OF OMEPRAZOLE AS ANTIMICROBIAL AGENT.
DE69510940T2 (en) PYRAZOLO AND PYRROLOPYRIDINE
PT797439E (en) USING PRAMIPEXOTE AS A NEUROPROTECTOR AGENT
ES2191292T3 (en) POLYAROMATIC ANTIVIRAL COMPOUNDS.
NO903286L (en) ANTIBACTERIAL AGENTS.
ES2096455T3 (en) APPLICATION OF LAMOTRIGINE IN THE TREATMENT OF NEUROSIDA.
MX9305248A (en) DIARILPIPERAZINOACETAMIDA COMPOUNDS.
ES8800160A1 (en) 5,6-Difluoronaphthyridines and 5,6,8-trifluoro-quinolines as antibacterial agents.
OA09917A (en) Compounds for use in treating HIV infection
DK312688A (en) GLYKKOPEPTID antibiotics
ID24184A (en) MEDICINE FOR TREATMENT OF EFFECTIVE DISFUNCTIONS
FI935780A (en) HIV protease inhibitors useful in the treatment of AIDS
ES2157899T3 (en) SAMPANGINA DERIVATIVES USEFUL AS ANTIFUNGIC AND ANTIMICOBACTERIAL AGENTS.
MD960168A (en) Method for treatment of viral infections and compounds therefor
DE69635806D1 (en) Diphosphonate derivatives of therapeutically active substances
MX9204845A (en) COMBINATIONS OF AMMONIUM CHLORIDE COMPOUNDS AND METHOD FOR THE TREATMENT OF VIRAL INFECTIONS.
ES2152315T3 (en) XAMONELINE TARTRATO.
IT1265647B1 (en) TOPICAL PHARMACEUTICAL COMPOSITION FOR RESPIRATORY ALLERGIES
AR005730A1 (en) FORM OF FANCICLOVIR, PROCEDURE FOR PREPARING IT, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT AND METHOD FOR THE TREATMENT OR PROPHYLAXIS OF VIRAL INFECTIONS AND THE USE OF SUCH FORM -FANCICLOVIR MONOIDRATE.
DK277387A (en) THERAPEUTIC TOPICAL COMPOSITION AGAINST A HYPERPROLIFIING EPITHAL DISEASE
ITRM920305A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF THE SHOCK, PARTICULARLY OF THE CARDIOGEN SHOCK AND SEPTIC SHOCK.
BR9106596A (en) PROCESS FOR THE TREATMENT OR PROPHYLAXIS OF AN INFECTION ASSOCIATED WITH RETROVIRUS, USE, PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PROPHYLAXIS OF AN INFECTION ASSOCIATED WITH RETROVIRUS, AND, COMPOUND
MX9503783A (en) Ammonium chloride compounds combinations for the treatment of viral infections.
ITRM920516A1 (en) COMPOSITION AND ITS USE FOR THE THERAPEUTIC TREATMENT OF DERMATITIC AFFECTIONS, ESPECIALLY PSORIASIS.
ES2139382T3 (en) PERCUTANEOUS THERAPEUTIC SYSTEM FOR SILATRAN COMPOUNDS.